| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.1994.12.10.2229 |
| P698 | PubMed publication ID | 7931493 |
| P2093 | author name string | S Hellman | |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2229-2234 | |
| P577 | publication date | 1994-10-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Karnofsky Memorial Lecture. Natural history of small breast cancers | |
| P478 | volume | 12 |
| Q37353932 | A modified radiofrequency ablation approach for treating distant lymph node metastasis in two patients with late-stage cancer |
| Q37327951 | A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis |
| Q34723820 | A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions |
| Q89585701 | Accelerating the development of therapeutic strategy for oligometastasis |
| Q54008491 | Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer. |
| Q33538442 | Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis |
| Q34033274 | Axillary surgery in breast cancer management--background, incidence and extent of nodal spread, extent of surgery and accurate axillary staging, surgical procedures |
| Q39569308 | Biomarkers of cancer metastasis through the lymphovascular system: future perspectives |
| Q74266799 | Breast cancer in the third millennium |
| Q37990821 | Breast cancer local therapy: what is its effect on mortality? |
| Q29618061 | Breast cancer metastasis: markers and models |
| Q38781885 | Breast cancer upregulating genes in stromal cells by LINE-1 hypermethylation and micrometastatic detection. |
| Q34562492 | Breast cancer: an introduction to the problem |
| Q37200395 | Cancer stem cells and therapeutic targets: an emerging field for cancer treatment |
| Q52591818 | Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis. |
| Q37187233 | Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach |
| Q37869333 | Clinical implications of cancer self-seeding |
| Q43412090 | Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study |
| Q37615072 | Clinical utility of aromatase inhibitors as adjuvant treatment in postmenopausal early breast cancer. |
| Q98153305 | Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes |
| Q38375864 | Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study |
| Q71075633 | Cost-effective preoperative evaluation, operative treatment, and postoperative follow-up in the breast cancer patient |
| Q50547499 | DBCG: the Danish Breast Cancer Cooperative Group--a 30-year struggle for better breast cancer treatment in Denmark. |
| Q73434443 | Darwin's clinical relevance |
| Q34768308 | Delay in adjuvant radiation treatment and outcomes of breast cancer--a review |
| Q36643900 | Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes |
| Q24803522 | Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase-polymerase chain reaction |
| Q35745259 | Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers |
| Q29615854 | EMT and dissemination precede pancreatic tumor formation |
| Q38430999 | Ecology meets cancer biology: the cancer swamp promotes the lethal cancer phenotype |
| Q63353119 | Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma |
| Q60958389 | Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity |
| Q50709872 | Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. |
| Q55400673 | Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes. |
| Q36337978 | Evolving paradigms and perceptions of cancer |
| Q73930711 | Factors in decision making in the treatment of breast cancer |
| Q48199116 | Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study. |
| Q43673656 | Fundamentals of contemporary surgical oncology: biologic principles and the threshold concept govern treatment and outcomes |
| Q57541460 | Gene-Expression Signatures in Breast Cancer |
| Q53548952 | Great expectations: historical perspectives on genetic breast cancer testing. |
| Q45988686 | Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. |
| Q38187353 | History of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery |
| Q24793476 | History of sentinel node and validation of the technique |
| Q53680068 | How to prevent invasive breast cancer: detect and excise duct carcinoma in situ. |
| Q92864450 | Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis |
| Q36555940 | Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy |
| Q58586691 | Identification of candidate genes or microRNAs associated with the lymph node metastasis of SCLC |
| Q50567683 | Impact of axillary dissection on staging and regional control in breast tumors < or = 10 mm--the DBCG experience. The Danish Breast Cancer Cooperative Group (DBCG), Rigshisoutalet, Copenhagen, Denmark. |
| Q50100934 | Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ |
| Q81430746 | Importance of local control in an era of systemic therapy |
| Q50547512 | Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry. |
| Q46861158 | Improving size, lymph node metastatic rate, breast conservation, and mortality of invasive breast cancer in Rhode Island women, a well-screened population |
| Q34013792 | Individual characterisation of the metastatic capacity of human breast carcinoma |
| Q78550438 | Internal mammary and medial supraclavicular lymph node irradiation: the thin line between advantages and side effects |
| Q73580657 | Intraoperative electron radiotherapy as a component of salvage therapy for patients with colorectal cancer and advanced nodal metastases |
| Q40744683 | Intravascular injections of a conditional replicative adenovirus (adl118) prevent metastatic disease in human breast carcinoma xenografts |
| Q36294948 | Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases |
| Q38683103 | Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin? |
| Q43908429 | Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer |
| Q72054637 | Long-term results of conservative surgery and radiation for early stage breast cancer: What have we wrought? |
| Q88733680 | Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials |
| Q61813951 | Lymph node resection induces the activation of tumor cells in the lungs |
| Q35575870 | Lymphangiogenesis and hemangiogenesis: potential targets for therapy |
| Q41600452 | Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread |
| Q34246641 | Management of non-small cell lung cancer with oligometastasis |
| Q38161337 | Metastatic tumor dormancy in cutaneous melanoma: does surgery induce escape? |
| Q38024323 | Metastatic view of breast cancer |
| Q37169164 | Minimal disease in sentinel nodes. |
| Q50316190 | Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery |
| Q38090228 | Molecular mechanisms and imaging of lymphatic metastasis |
| Q87649909 | Multidisciplinary therapy for patients with locally oligo-recurrent pelvic malignancies |
| Q38153442 | New concepts and insights into the role of radiation therapy in extracranial metastatic disease |
| Q36615425 | No common denominator for breast cancer lymph node metastasis |
| Q37725741 | Oligometastases confined one organ from colorectal cancer treated by SBRT. |
| Q34748629 | Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options |
| Q38091331 | Oligometastases: the new paradigm and options for radiotherapy. A critical review |
| Q50954857 | P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice. |
| Q30814926 | Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. |
| Q35603931 | Patient Delay in Accessing Breast Cancer Care in a Sub Saharan African Country: Uganda |
| Q38005345 | Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review |
| Q86134561 | Postmastectomy radiotherapy in patients with breast cancer |
| Q34397789 | Postmastectomy radiotherapy in women with breast cancer metastatic to one to three axillary lymph nodes |
| Q33667632 | Postmastectomy radiotherapy: future directions |
| Q40094272 | Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience |
| Q47178452 | Predicting the survival of patients with breast carcinoma using tumor size |
| Q41408181 | Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment |
| Q77687382 | Presidential address: beyond risk groups--a new look at differentiated thyroid cancer |
| Q36134965 | Prognosis of younger and older patients with early breast cancer |
| Q27001734 | Progression of cutaneous melanoma: implications for treatment |
| Q34124296 | Radical irradiation of extracranial oligometastases |
| Q40945488 | Roentgen Centennial Lecture: discovering the past, inventing the future |
| Q33972653 | Role of axillary surgery in early breast cancer: review of the current evidence |
| Q33667592 | Role of postmastectomy radiotherapy: A medical oncology perspective |
| Q35555487 | Significance of lymph node metastasis in cancer dissemination of head and neck cancer |
| Q64074521 | Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview |
| Q58131317 | Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity |
| Q57177641 | Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions |
| Q34320125 | Stereotactic body radiotherapy for oligometastases. |
| Q38808288 | Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting? |
| Q52991385 | Successful radiotherapy for repeated recurrent uterine clear cell adenocarcinoma. |
| Q33779166 | Surgical considerations for invasive breast cancer |
| Q38707804 | Surveillance of anal carcinoma after radiochemotherapy : A retrospective analysis of 80 patients. |
| Q50516688 | Tagging sentinel lymph nodes: a study of 100 patients with breast cancer. |
| Q45825533 | The 20-year effort to reduce access to mammography screening: historical facts dispute a commentary in Cancer |
| Q43740652 | The European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group: quality control of surgical trials. |
| Q55038014 | The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent. |
| Q50594757 | The Importance of Local Control in the Conservative Treatment of Breast Cancer |
| Q37099065 | The Lymphatic System in Disease Processes and Cancer Progression |
| Q74608079 | The benefits of mammography are not limited to women of ages older than 50 years |
| Q35832153 | The biology and treatment of oligometastatic cancer |
| Q37944487 | The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival |
| Q73833521 | The life-sparing potential of mammographic screening |
| Q43774018 | The link between local recurrence and distant metastases in human breast cancer |
| Q53620667 | The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma. |
| Q33779144 | The natural history of breast cancer |
| Q46288612 | The oligometastatic state - separating truth from wishful thinking |
| Q36612312 | The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983-1999. |
| Q52564354 | The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. |
| Q30248748 | The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope. |
| Q42198302 | The role of lymph node metastasis in the systemic dissemination of breast cancer |
| Q35008154 | The specialist breast unit and breast surgery as a specialty |
| Q36552769 | The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study |
| Q39436941 | The value of axillary dissection in T1a breast cancer |
| Q92839439 | Treatment of false-negative metastatic lymph nodes by a lymphatic drug delivery system with 5-fluorouracil |
| Q40809657 | Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival |
| Q44913660 | Tumor volume successively reflects the state of disease progression in endometrial cancer. |
| Q34580038 | Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma. |
| Q31119649 | Use of a lectin affinity selector in the search for unusual glycosylation in proteomics |
| Q73335120 | Use of primary breast carcinoma characteristics to predict lymph node metastases |
| Q74404989 | Use of primary breast carcinoma characteristics to predict lymph node metastases--reply |
| Q38324281 | Using tumour phylogenetics to identify the roots of metastasis in humans. |
| Q43566380 | Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death |
| Q50506452 | [Lymph node mapping and axillary sentinel lymph node biopsy in 243 invasive breast cancers with no palpable nodes. The south Lyon hospital center experience]. |
| Q74602369 | mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients |
Search more.